Metabolic Blood Markers That Actually Matter — and Which Are Overrated | ALIV

Most standard health checkup panels in India include fasting glucose, a lipid profile, and perhaps HbA1c. These are useful. They are also insufficient for catching insulin resistance early — which is where the vast majority of metabolic disease begins, years before the markers most doctors are watching become abnormal. Here is the complete panel worth having.

The Markers That Genuinely Explain Metabolic Risk

Fasting insulin. The single most underordered test in metabolic medicine in India. Fasting glucose tells you where your blood sugar is. Fasting insulin tells you how hard your pancreas is working to keep it there. A fasting glucose of 95 mg/dL with a fasting insulin of 22 mIU/L is a very different clinical picture from the same glucose with a fasting insulin of 6 mIU/L — the first is significant insulin resistance, the second is normal sensitivity. HOMA-IR calculated from both gives you a direct insulin resistance measurement. See our dedicated guide: insulin resistance explained.

Triglycerides. Elevated fasting triglycerides — particularly above 150 mg/dL — are strongly associated with insulin resistance, visceral fat accumulation, and cardiovascular risk. The triglyceride-to-HDL ratio (TG/HDL) is one of the most sensitive and accessible indicators of insulin resistance in clinical practice: a ratio above 3.0 in Indian patients is a meaningful metabolic red flag even when fasting glucose is normal.

HDL cholesterol. High HDL is protective; low HDL (below 40 mg/dL in men, below 50 mg/dL in women) is independently associated with insulin resistance and metabolic syndrome. Low HDL alongside high triglycerides is the lipid dyslipidaemia pattern most characteristic of insulin resistance — and the one most commonly missed when clinicians focus only on total cholesterol and LDL.

Uric acid. Elevated uric acid (hyperuricaemia) — often thought of primarily in the context of gout — is closely associated with insulin resistance, fructose overconsumption, and visceral fat accumulation. It is a useful metabolic marker that provides additional texture to the picture when elevated.

High-sensitivity CRP (hsCRP). CRP is an inflammatory marker. Elevated hsCRP — even at levels below the "abnormal" range — reflects the chronic low-grade inflammation that accompanies insulin resistance and visceral adiposity. An hsCRP between 1 and 3 mg/L represents moderate cardiovascular risk; above 3 mg/L is high risk. This is distinct from the CRP elevation seen with acute infection, which is typically in the range of hundreds.

HbA1c. A three-month average of blood sugar — genuinely useful for identifying established glucose dysregulation. However, HbA1c becomes abnormal after insulin resistance has already been present for years. It is a late marker — important but not sufficient for early detection.

The Markers That Are Often Overemphasised

Total cholesterol alone. Total cholesterol without the HDL, LDL, and triglyceride breakdown is essentially meaningless for individual risk assessment. A total cholesterol of 220 mg/dL with high HDL and low triglycerides is a vastly different picture from the same total cholesterol with low HDL and high triglycerides.

LDL cholesterol from standard calculation. Most Indian labs calculate LDL using the Friedewald equation, which becomes unreliable at high triglyceride levels — a very common scenario in insulin-resistant patients. Direct LDL measurement or apolipoprotein B (apoB) testing gives a more accurate picture when triglycerides are elevated.

Fasting glucose alone. As established above — insufficient for early insulin resistance detection without fasting insulin alongside it.

Building Your Metabolic Panel

The minimum useful metabolic panel for urban Indian adults: fasting glucose + fasting insulin (for HOMA-IR), HbA1c, full lipid profile including TG/HDL ratio, uric acid, hsCRP, and waist circumference measured on the day. Read our weight and metabolic health guide: metabolic health in India.

How often should metabolic blood markers be checked?

For adults in their 30s and beyond with no known metabolic issues: annually is appropriate. For patients with confirmed insulin resistance or prediabetes: every three to six months during active management to track response to interventions. For patients on a structured metabolic programme — including IV support at ALIV — repeat markers at the end of each clinical course (typically eight to twelve weeks).

Can I have "normal" metabolic markers but still have metabolic syndrome?

It depends on which markers are tested. The clinical definition of metabolic syndrome requires at least three of five criteria: elevated waist circumference, elevated fasting glucose, elevated triglycerides, low HDL, and elevated blood pressure. A patient can meet three criteria (waist, triglycerides, blood pressure) with normal fasting glucose and normal total cholesterol — and receive "all normal" on a standard limited panel that did not check waist circumference or triglycerides. The completeness of the panel determines how complete the picture is.

What does a high TG/HDL ratio mean?

A triglyceride-to-HDL ratio above 3.0 — particularly in Indian patients — is one of the most accessible indicators of underlying insulin resistance in clinical practice. It reflects the lipid signature that insulin resistance produces: elevated triglycerides from impaired triglyceride clearance, and low HDL from the same metabolic dysfunction. Addressing the underlying insulin resistance through diet, exercise, and targeted clinical support typically improves the TG/HDL ratio over months.

Should I fast before every blood test related to metabolic health?

Fasting (8–10 hours) is required for: fasting glucose, fasting insulin, fasting triglycerides, and the full fasting lipid profile. It is not required for: HbA1c, hsCRP, uric acid, ferritin, or thyroid markers. If you are having a comprehensive panel done and some markers require fasting, fast for all of them to avoid two separate draws.

My doctor says my results are "all normal." Should I be satisfied?

Ask specifically: was fasting insulin included? Was TG/HDL ratio calculated? Was uric acid tested? Was hsCRP measured? Was waist circumference recorded? If the answer to most of these is no, the panel may not be complete enough to rule out early-stage insulin resistance and metabolic dysfunction. The difference between "all normal" and "metabolically optimised" is a function of what was and was not tested